Conference Coverage

Tool predicts lymphoma, death in primary Sjögren’s syndrome patients


 

FROM THE EULAR CONGRESS 2014

Since the analysis of these 921 patients was completed in January 2013, an additional 124 patients with primary SS have joined the cohort. In this larger cohort, baseline ESDAI score of 14 or higher and presence of more than one laboratory marker (lymphopenia, low cryoglobulins, hypocomplementemia, and monoclonal band) both were significantly associated with SS-related death.

Dr. Brito Zerón noted that the investigators have not analyzed whether treatment influenced outcomes in the cohort, but they plan to.

The investigators had no financial disclosures.

Pages

Recommended Reading

Treat to target shows durable improvements in psoriatic arthritis
MDedge Family Medicine
Different triggers found for knee and hand OA
MDedge Family Medicine
Sarilumab shown safe, effective for RA in phase III trial
MDedge Family Medicine
International RA risk tool for CVD comes closer to reality
MDedge Family Medicine
Gut inflammation linked to worsening spondyloarthritis
MDedge Family Medicine
Tofacitinib bests methotrexate for RA
MDedge Family Medicine
FVC inadequate when assessing scleroderma lung disease
MDedge Family Medicine
Stem-cell transplants growing routine for severe scleroderma
MDedge Family Medicine
VIDEO: Gene profiling could signal start of personalized medicine in RA
MDedge Family Medicine
Higher risk of death seen with oral steroids in RA interstitial lung disease
MDedge Family Medicine